Skip to content

Prevalence of Pancreatic Cysts During Routine Endoscopic Ultra Sound

Prevalence of Pancreatic Cysts During Routine EUS

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01624363
Enrollment
341
Registered
2012-06-20
Start date
2009-09-30
Completion date
2015-06-30
Last updated
2017-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cysts

Keywords

Pancreatic cysts incidentally found during EUS

Brief summary

The investigators are interested in performing a detailed examination of the pancreas via EUS (Endoscopic Ultra Sound)for patients referred for a non-pancreatic condition. The hypothesis is to make a statistical determination of how many pancreatic cysts the investigators discover incidentally.

Detailed description

The prevalence of incidental pancreatic cysts discovered during EUS. (see data tables)

Interventions

None listed

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* The inclusion criteria included: patients \>18 years old with decision making capacity referred for EUS for any other indication other than the evaluation of a known pancreatic cyst, solid mass, or suspected mass.

Exclusion criteria

* Any known history or evidence of the following from any previous imaging study: pancreatic cyst, solid mass, suspected pancreatic mass, dilated main pancreatic duct * Previous surgical resection of any portion of the upper GI tract such as Billroth II that would not permit complete EUS exam of the pancreas * Laboratory and/or clinical evidence of ongoing acute pancreatitis * Previous pancreatic surgical resection * Pregnancy * Incarceration * High risk for sedation * Coagulopathy and/or thrombocytopenia * The patients underwent a complete EUS examination of the pancreas.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of Pancreatic Cysts During Routine EUS48 monthsThe purpose of this study is to identify the prevalence of pancreatic cysts in patients undergoing EUS for non-pancreatic indications .

Countries

United States

Participant flow

Participants by arm

ArmCount
Patients Undergoing EUS
Patients undergoing EUS for non-pancreatic treatment. Diagnosis of a previously undetected pancreatic cyst: patients identified to have a pancreatic cyst, will need to be followed via imaging studies.
341
Total341

Baseline characteristics

CharacteristicPatients Undergoing EUS
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
113 Participants
Age, Categorical
Between 18 and 65 years
228 Participants
Region of Enrollment
United States
341 participants
Sex: Female, Male
Female
187 Participants
Sex: Female, Male
Male
154 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 314
serious
Total, serious adverse events
0 / 341

Outcome results

Primary

Prevalence of Pancreatic Cysts During Routine EUS

The purpose of this study is to identify the prevalence of pancreatic cysts in patients undergoing EUS for non-pancreatic indications .

Time frame: 48 months

ArmMeasureValue (MEDIAN)
Patients Undergoing EUSPrevalence of Pancreatic Cysts During Routine EUS46 participants found to have a cyst

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026